Migliaccio & Rathod LLP is currently investigating the Florida-based Central Florida Inpatient Medicine (“CFIM”), which recently notified 197,733 patients that their protected health information was in an employee email account that was accessed by an unauthorized third-party between August 21, 2021 and September 17, 2021. The impacted information includes the following: names, dates of birth, medical information including diagnosis and/or clinical treatment information, physician and/or hospital name, dates of service, health insurance information, Social Security numbers, driver’s license numbers, financial account information, and usernames and passwords.
CFIM only recently began notifying victims of the data breach. Due to this lapse in time between the data breach and the notice to affected patients, as well as the almost month-long access the unauthorized cybercriminal(s) had to the impacted information, hackers may have already been able to acquire and sell the impacted sensitive information and otherwise benefit from the fraudulent misuse of such information. Some individuals affected by the data breach may have already noticed (or may soon notice) one or more of the following types of fraudulent activity related to their personal and health information: unauthorized credit card inquiries and/or charges, requests for loans or benefits in a patient’s name without their consent, fake medical procedures ordered, and/or disrupted use of the institution’s website or patient portal.
Are you or have you been a Central Florida Inpatient Medicine patient who recently received a data breach notification letter?
If so, we would like to hear from you. Please complete the contact form on this page, send us an email at firstname.lastname@example.org, or give us a call at (202) 470-3520.
The lawyers at Migliaccio & Rathod LLP have years of experience in class action litigation against large corporations, including in cases involving data breaches. More information about our current cases and investigations is available on our blog.